Clinical Trials Logo

Filter by:
NCT ID: NCT03040973 Recruiting - Clinical trials for Advanced Solid Tumors Which Are cMET-dependent

Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone

Start date: July 4, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess long-term safety and provide continued study treatment access to eligible participants who are judged by the Investigator to benefit from continued treatment with capmatinib monotherapy or in combination with other treatments or with the combination treatment alone in a Novartis sponsored study

NCT ID: NCT03040180 Recruiting - Neoadjuvant Therapy Clinical Trials

Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer

nECT
Start date: January 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of neoadjuvant electrochemotherapy on locally advanced rectal cancer (UICC II-III) in an intended curative clinical setting, using an endoscopic electroporation device (EndoVE).

NCT ID: NCT03031106 Recruiting - Clinical trials for Malignant Hematologic Neoplasm

Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease

Start date: January 2017
Phase: N/A
Study type: Observational

The aim of this study is to adjust and test an existing internet-based tool for collecting patient-reported outcome measures and to use the internet-based tool in an multidisciplinary follow-up of patients treated for malignant hematological diseases. The patient-reported outcome measurements will be used in describing the patients' health-related quality of life (HRQoL) and to investigate whether the HRQol will increase due to participation in multidisciplinary follow-up.

NCT ID: NCT03016910 Recruiting - Atherosclerosis Clinical Trials

Coronary Artery Plaque Burden and Morphology in Type 2 Diabetes Mellitus.

CARPEDIEM
Start date: March 2016
Phase: N/A
Study type: Observational

Unstable plaque, the primary cause of myocardial infarction, is characterized by distinct a morphology including positive remodeling (PR), low attenuated plaque (LAP), napkin ring sign (NRS), and spotty calcifications (SC) The purpose of the present study is to investigate the influence of microvascular dysfunction and additional risk factors on plaque morphology and plaque burden in patients with diabetes mellitus.

NCT ID: NCT02995317 Recruiting - Accidental Fall Clinical Trials

Who is Falling? - Fall Risk Prediction Among Community Dwelling Elderly.

NOCfao
Start date: December 2016
Phase:
Study type: Observational

The purpose of this study is to investigate if the level of physical activity, selected physical and psychological risk factors can predict risk of falling in older (≥65) community dwellers.

NCT ID: NCT02988128 Recruiting - Stroke, Ischemic Clinical Trials

Neurovascular Product Surveillance Registry

INSPIRE
Start date: December 2016
Phase:
Study type: Observational [Patient Registry]

Post market surveillance registry

NCT ID: NCT02987101 Recruiting - Leg Ulcer Clinical Trials

Treatment of Chronic Leg Ulcers With Autologous Stromal Vascular Fraction

Start date: November 2016
Phase: N/A
Study type: Interventional

Chronic leg ulcers are associated with decreased quality of life and an increased mortality. In many cases these ulcers are treated conservatively and the healing time can be several months. In this open randomized clinical trial we will examine if we can accelerate wound healing when using autologous stromal vascular fraction as an adjunct to standard wound care.

NCT ID: NCT02979119 Recruiting - Clinical trials for Factor VIII Deficiency

The European Paediatric Network for Haemophilia Management ( PedNet Registry)

PedNet
Start date: June 2014
Phase:
Study type: Observational [Patient Registry]

Rationale: Haemophilia is a rare disease; to improve knowledge international collaboration is needed. Well-defined clinical data will be collected from complete cohorts in order to prevent selection bias. Objective: To collect data on bleeding during neonatal period, endogenous (genetic) and exogenous (treatment-related) determinants of inhibitor development and long term outcome.

NCT ID: NCT02976051 Recruiting - Radiotherapy Clinical Trials

DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC

Start date: January 2017
Phase: Phase 2
Study type: Interventional

Aim: To improve curability of radiotherapy in HNSCC patients identified by hypoxic FAZA-PET scanning

NCT ID: NCT02974920 Recruiting - Thrombosis Clinical Trials

Rivaroxaban or Aspirin for Biological Aortic Prosthesis

Start date: January 1, 2017
Phase: Phase 4
Study type: Interventional

Aortic valve replacement with a biological prosthesis is the most common valve surgery performed with about 1000 operations performed in Denmark each year. Further, the introduction of percutaneous stent valves will increase these types of replacements in the years to come. A biological valve is a foreign body prone to cause thrombus formation at least until the valve is covered with recipient endothelium. There are no conclusive studies of anticoagulation and the investigators have shown stroke to be a common complication. Guidelines have variably recommended aspirin or rivaroxaban for anticoagulation, and currently aspirin is the most common recommendation. In a register study, the investigators have shown that proper anticoagulation with warfarin is likely to be superior. There is a clear need for a large randomised study of aspirin versus anticoagulation for biological aortic valve replacement. This protocol describes a randomised study where 1000 patients will be randomised to receive either rivaroxaban or aspirin for 6 months following aortic valve replacement with a biological prosthesis. The primary efficacy endpoint is a combined event of all-cause mortality and hospitalisation for either acute myocardial infarction or stroke. This study has the power to settle a discussion of appropriate anticoagulation for this operation